loadpatents
name:-0.010262012481689
name:-0.0049939155578613
name:-0.0027370452880859
Tsai; Ping-Chuan Patent Filings

Tsai; Ping-Chuan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tsai; Ping-Chuan.The latest application filed is for "hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists".

Company Profile
2.6.9
  • Tsai; Ping-Chuan - Stanford CA
  • Tsai; Ping-Chuan - Fremont CA
  • Tsai; Ping-Chuan - New Taipei TW
  • Tsai; Ping-Chuan - New Taipei City TW
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Hepatocyte Growth Factor Fragments That Function As Potent Met Receptor Agonists And Antagonists
App 20220033453 - Cochran; Jennifer R. ;   et al.
2022-02-03
Fusion Proteins Comprising an Engineered Knottin Peptide and Uses Thereof
App 20210206824 - Cochran; Jennifer R. ;   et al.
2021-07-08
Fusion proteins comprising an engineered knottin peptide and uses thereof
Grant 10,844,106 - Cochran , et al. November 24, 2
2020-11-24
AC-OK detection circuit and method
Grant 10,630,105 - Tsai , et al.
2020-04-21
Ac-ok Detection Circuit And Method
App 20190067987 - Tsai; Ping-Chuan ;   et al.
2019-02-28
Data transmission system and communication method
Grant 10,085,204 - Chiang , et al. September 25, 2
2018-09-25
Hepatocyte Growth Factor Fragments that Function as Potent Met Receptor Agonists and Antagonists
App 20170305985 - COCHRAN; Jennifer R. ;   et al.
2017-10-26
Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists
Grant 9,556,248 - Cochran , et al. January 31, 2
2017-01-31
Data Transmission System And Communication Method
App 20160278005 - CHIANG; CHI-KANG ;   et al.
2016-09-22
Fusion Proteins Comprising An Engineered Knottin Peptide And Uses Thereof
App 20140073518 - Cochran; Jennifer R. ;   et al.
2014-03-13
Hepatocyte Growth Factor Fragments That Function As Potent Met Receptor Agonists And Antagonists
App 20130171068 - Cochran; Jennifer R. ;   et al.
2013-07-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed